Letter to the EditorInternational Journal of Advances in Medicine

Publication:
Unveiling the occurrence of diabetic ketoacidosis with SGLT2 Inhibitors: need for vigilance and careful monitoring

Int J Adv Med. 2023;10(6):496-497.DOI10.18203/2349-3933.ijam20231460

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

With great interest, we have read the case report titled “Euglycemic diabetic ketoacidosis (DKA)-a rare side effect of sodium-glucose co-transporter-2 inhibitor in a patient of type 2 diabetes mellitus with left ventricular dysfunction: a case report” published in the international journal of advances in medicine.

Affiliations

  1. Department of Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
  2. Department of Medicine, College of Medicine, Gulf Medical University, Ajman, UAE
  3. Department of Medicine, Sri Ramachandra Institute of higher education and research, Chennai, Tamil Nadu, India
  4. Department of Medicine, Siddhartha Medical College, Vijayawada, Andhra Pradesh, India

Full item record